The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Glial cells and adaptive immunity in frontotemporal dementia with tau pathology
Abstract
Neuroinflammation is involved in the aetiology of many neurodegenerative disorders including Alzheimer’s disease, Parkinson’s disease and motor neuron disease. Whether neuroinflammation also plays an important role in the pathophysiology of frontotemporal dementia is less well known. Frontotemporal dementia is a heterogeneous classification that covers many subtypes, with the main pathology known as frontotemporal lobar degeneration. The disease can be categorized with respect to the identity of the protein that causes the frontotemporal lobar degeneration in the brain. The most common subgroup describes diseases caused by frontotemporal lobar degeneration associated with tau aggregation, also known as primary tauopathies. Evidence suggests that neuroinflammation may play a role in primary tauopathies with genome-wide association studies finding enrichment of genetic variants associated with specific inflammation-related gene loci. These loci are related to both the innate immune system, including brain resident microglia, and the adaptive immune system through possible peripheral T-cell involvement. This review discusses the genetic evidence and relates it to findings in animal models expressing pathogenic tau as well as to post-mortem and PET studies in human disease. Across experimental paradigms, there seems to be a consensus regarding the involvement of innate immunity in primary tauopathies, with increased microglia and astrocyte density and/or activation, as well as increases in pro-inflammatory markers. Whilst it is less clear as to whether inflammation precedes tau aggregation or vice versa; there is strong evidence to support a microglial contribution to the propagation of hyperphosphorylated in tau frontotemporal lobar degeneration associated with tau aggregation. Experimental evidence—albeit limited—also corroborates genetic data pointing to the involvement of cellular adaptive immunity in primary tauopathies. However, it is still unclear whether brain recruitment of peripheral immune cells is an aberrant result of pathological changes or a physiological aspect of the neuroinflammatory response to the tau pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As gliosis begins as early as 2 months in the rTg4510 model (19–21)”
From Pathogenic tau–induced transposable element–derived dsRNA drives neuroinflammation (2023) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
Genomic analysis of reactive astrogliosis
Zamanian, J. L., Xu, L., Foo, L. C., Nouri, N., Zhou, L., Giffard, R. G., & Barres, B. A. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6221-11.2012 · Cited by 2,404
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208
Microglia emerge as central players in brain disease
Salter, M. W., & Stevens, B. (2017) · Nature Medicine · doi:10.1038/nm.4397 · Cited by 1,767
Depletion of microglia and inhibition of exosome synthesis halt tau propagation
Asai, H., Ikezu, S., Tsunoda, S., Medalla, M., Luebke, J., Haydar, T., Wolozin, B., Butovsky, O., Kügler, S., & Ikezu, T. (2015) · Nature Neuroscience · doi:10.1038/nn.4132 · Cited by 1,591
NLRP3 inflammasome activation drives tau pathology
Ising, C., Venegas, C., Zhang, S., Scheiblich, H., Schmidt, S. V., Vieira-Saecker, A., Schwartz, S., Albasset, S., McManus, R. M., Tejera, D., et al. (2019) · Nature · doi:10.1038/s41586-019-1769-z · Cited by 1,487
Self-citationAstrocytes are active players in cerebral innate immunity
Farina, C., Aloisi, F., & Meinl, E. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.01.005 · Cited by 1,304
Normal aging induces A1-like astrocyte reactivity
Clarke, L. E., Liddelow, S. A., Chakraborty, C., Münch, A. E., Heiman, M., & Barres, B. A. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800165115 · Cited by 1,237
ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy
Initiative, A. D. N., Shi, Y., Yamada, K., Liddelow, S. A., Smith, S. T., Zhao, L., Luo, W., Tsai, R. M., Spina, S., Grinberg, L. T., et al. (2017) · Nature · doi:10.1038/nature24016 · Cited by 1,220
Research works printed but not linked: 135
- Abu-Rumeileh, 2019, CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia, Alzheimers Res Ther, 12, 2, 10.1186/s13195-019-0562-4 · DOI
- Agosta, 2009, Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia, Proc Natl Acad Sci USA, 106, 2018, 10.1073/pnas.0812697106 · DOI · Paper page
- Ahmed, 2015, Rescue of impaired late-phase long-term depression in a tau transgenic mouse model, Neurobiol Aging, 36, 730, 10.1016/j.neurobiolaging.2014.09.015 · DOI
- Ajmone-Cat, 2019, Increased FUS levels in astrocytes leads to astrocyte and microglia activation and neuronal death, Sci Rep, 9, 4572, 10.1038/s41598-019-41040-4 · DOI
- Allen, 2002, Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein, J Neurosci, 22, 9340, 10.1523/JNEUROSCI.22-21-09340.2002 · DOI · Paper page
- Amin, 2017, What do we know about the inflammasome in humans?, Brain Pathol, 27, 192, 10.1111/bpa.12479 · DOI
- Andreasson, 2001, Age-dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice, J Neurosci, 21, 8198, 10.1523/JNEUROSCI.21-20-08198.2001 · DOI · Paper page
- Babcock, 2003, Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS, J Neurosci, 23, 7922, 10.1523/JNEUROSCI.23-21-07922.2003 · DOI · Paper page
- Barker, 2002, Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank, Alzheimer Dis Assoc Disord, 16, 203, 10.1097/00002093-200210000-00001 · DOI · Paper page
- Bellucci, 2004, Induction of inflammatory mediators and microglial activation in mice transgenic for mutant human P301S tau protein, Am J Pathol, 165, 1643, 10.1016/S0002-9440(10)63421-9 · DOI · Paper page
- Beyer, 2018, Translocator protein 18kDa (TSPO) expression in patients with clinically diagnosed progressive supranuclear palsy, J Nucl Med, 59, 1700
- Bigio, 1999, Progressive supranuclear palsy with dementia: cortical pathology, J Neuropathol Exp Neurol, 58, 359, 10.1097/00005072-199904000-00006 · DOI
- Boccardi, 2004, APOE and modulation of Alzheimer's and frontotemporal dementia, Neurosci Lett, 356, 167, 10.1016/j.neulet.2003.11.042 · DOI
- Boche, 2013, Review: activation patterns of microglia and their identification in the human brain, Neuropathol Appl Neurobiol, 39, 3, 10.1111/nan.12011 · DOI · Paper page
- Bonham, 2018, CXCR4 involvement in neurodegenerative diseases, Transl Psychiatry, 8, 73, 10.1038/s41398-017-0049-7 · DOI
- Bouwmeester, 2004, A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway, Nat Cell Biol, 6, 97, 10.1038/ncb1086 · DOI · Paper page
- Boxer, 2013, Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug development, Alzheimers Dement, 9, 176, 10.1016/j.jalz.2012.03.002 · DOI
- Broce, 2018, Immune-related genetic enrichment in frontotemporal dementia: an analysis of genome-wide association studies, PLoS Med, 15, e1002487, 10.1371/journal.pmed.1002487 · DOI · Paper page
- Brodie, 1998, Functional IL-4 receptors on mouse astrocytes: IL-4 inhibits astrocyte activation and induces NGF secretion, J Neuroimmunol, 81, 20, 10.1016/S0165-5728(97)00154-9 · DOI
- Burnouf, 2013, NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model, Aging Cell, 12, 11, 10.1111/acel.12018 · DOI
- Carvalho, 2019, Exacerbation of C1q dysregulation, synaptic loss and memory deficits in tau pathology linked to neuronal adenosine A2A receptor, Brain, 142, 3636, 10.1093/brain/awz288 · DOI
- Chouery, 2008, Mutations in TREM2 lead to pure early-onset dementia without bone cysts, Hum Mutat, 29, E194, 10.1002/humu.20836 · DOI
- Corder, 1993, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, 261, 921, 10.1126/science.8346443 · DOI · Paper page
- Cuyvers, 2014, Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia, Neurobiol Aging, 35, 726.e11, 10.1016/j.neurobiolaging.2013.09.009 · DOI · Paper page
- Dachsel, 2007, Lrrk2 G2019S substitution in frontotemporal lobar degeneration with ubiquitin-immunoreactive neuronal inclusions, Acta Neuropathol, 113, 601, 10.1007/s00401-006-0178-1 · DOI
- Dale, 2017, Inflammatory pathology and rapidly progressive dementia contribute to the classic PSP phenotype (P4.014), Neurology, 88, P4, 10.1212/WNL.88.16_supplement.P4.014 · doi:10.1212/wnl.88.16_supplement.p4.014
- Darwent, 2017, Mutations in TYROBP are not a common cause of dementia in a Turkish cohort, Neurobiol Aging, 58, 240.e1, 10.1016/j.neurobiolaging.2017.06.019 · DOI
- Das, 2020, Phagocytosis of full-length Tau oligomers by Actin-remodeling of activated microglia, J Neuroinflammation, 17, 10, 10.1186/s12974-019-1694-y · DOI
- Davies, 2017, Microglia show altered morphology and reduced arborization in human brain during aging and Alzheimer's disease, Brain Pathol, 27, 795, 10.1111/bpa.12456 · DOI · Paper page
- Dennis, 2016, Human adult neurogenesis across the ages: an immunohistochemical study, Neuropathol Appl Neurobiol, 42, 621, 10.1111/nan.12337 · DOI · Paper page
- Dickson, 2011, Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau), J Mol Neurosci, 45, 384, 10.1007/s12031-011-9589-0 · DOI · Paper page
- Espeseth, 2008, Accelerated age-related cortical thinning in healthy carriers of apolipoprotein E epsilon 4, Neurobiol Aging, 29, 329, 10.1016/j.neurobiolaging.2006.10.030 · DOI
- Fahrenhold, 2018, TREM2 expression in the human brain: a marker of monocyte recruitment?, Brain Pathol, 28, 595, 10.1111/bpa.12564 · DOI
- Farrer, 1997, Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium, JAMA, 278, 1349, 10.1001/jama.1997.03550160069041 · DOI · Paper page
- Fennema-Notestine, 2011, Presence of ApoE ε4 allele associated with thinner frontal cortex in middle age, J Alzheimers Dis, 26, 49, 10.3233/JAD-2011-0002 · DOI
- Ferrari, 2016, Frontotemporal dementia: insights into the biological underpinnings of disease through gene co-expression network analysis, Mol Neurodegener, 11, 21, 10.1186/s13024-016-0085-4 · DOI
- Ferrari, 2017, Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases, J Neurol Neurosurg Psychiatry, 88, 152, 10.1136/jnnp-2016-314411 · DOI
- Franco-Bocanegra, 2018, Innate immunity in Alzheimer's disease: the relevance of animal models?, J Neural Transm, 125, 827, 10.1007/s00702-017-1729-4 · DOI
- Galimberti, 2015, Inflammatory molecules in Frontotemporal Dementia: cerebrospinal fluid signature of progranulin mutation carriers, Brain Behav Immun, 49, 182, 10.1016/j.bbi.2015.05.006 · DOI
- Gendreau, 2013, Tangles, toxicity, and tau secretion in ad - new approaches to a vexing problem, Front Neurol, 4, 160, 10.3389/fneur.2013.00160 · DOI
- Geschwind, 1998, The apolipoprotein E epsilon4 allele is not a significant risk factor for frontotemporal dementia, Ann Neurol, 44, 134, 10.1002/ana.410440122 · DOI
- Ghetti, 2015, Invited review: frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging, Neuropathol Appl Neurobiol, 41, 24, 10.1111/nan.12213 · DOI · Paper page
- Ginhoux, 2010, Fate mapping analysis reveals that adult microglia derive from primitive macrophages, Science, 330, 841, 10.1126/science.1194637 · DOI · Paper page
- Gorno-Tempini, 2011, Classification of primary progressive aphasia and its variants, Neurology, 76, 1006, 10.1212/WNL.0b013e31821103e6 · DOI · Paper page
- Hall, 2018, Cerebrospinal fluid concentrations of inflammatory markers in Parkinson's disease and atypical parkinsonian disorders, Sci Rep, 8, 13276, 10.1038/s41598-018-31517-z · DOI
- Hampton, 2010, Cell-mediated neuroprotection in a mouse model of human tauopathy, J Neurosci, 30, 9973, 10.1523/JNEUROSCI.0834-10.2010 · DOI
- Hardy, 2014, Motor neuron disease and frontotemporal dementia: sometimes related, sometimes not, Exp Neurol, 262, 75, 10.1016/j.expneurol.2013.11.006 · DOI
- Harvey, 2003, The prevalence and causes of dementia in people under the age of 65 years, J Neurol Neurosurg Psychiatry, 74, 1206, 10.1136/jnnp.74.9.1206 · DOI · Paper page
- Hauw, 1994, Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy), Neurology, 44, 2015, 10.1212/WNL.44.11.2015 · DOI · Paper page
- Helboe, 2017, Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model, Brain Res, 1665, 22, 10.1016/j.brainres.2017.04.002 · DOI
- Henderson, 2019, Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease, Acta Neuropathol Commun, 7, 183, 10.1186/s40478-019-0836-x · DOI · Paper page
- Henstridge, 2019, Glial contribution to excitatory and inhibitory synapse loss in neurodegeneration, Front Cell Neurosci, 13, 63, 10.3389/fncel.2019.00063 · DOI
- Herx, 2001, Interleukin-1β is required for the early evolution of reactive astrogliosis following CNS lesion, J Neuropathol Exp Neurol, 60, 961, 10.1093/jnen/60.10.961 · DOI
- Hoffmann, 2013, Impaired plasticity of cortical dendritic spines in P301S tau transgenic mice, Acta Neuropathol Commun, 1, 82, 10.1186/2051-5960-1-82 · DOI
- Hogan, 2016, The prevalence and incidence of frontotemporal dementia: a systematic review, Can J Neurol Sci, 43, S96, 10.1017/cjn.2016.25 · DOI · Paper page
- Hollister, 1997, Neuronal expression of class II major histocompatibility complex (HLA-DR) in 2 cases of Pick disease, Arch Neurol, 54, 243, 10.1001/archneur.1997.00550150011008 · DOI
- Huang, 2011, FUS transgenic rats develop the phenotypes of amyotrophic lateral sclerosis and frontotemporal lobar degeneration, PLoS Genet, 7, e1002011, 10.1371/journal.pgen.1002011 · DOI · Paper page
- Hudson, 2005, Astrocytes and microglia differentially regulate trafficking of lymphocyte subsets across brain endothelial cells, Brain Res, 1058, 148, 10.1016/j.brainres.2005.07.071 · DOI
- Inbar, 2010, Possible role of tau in mediating pathological effects of apoE4 in vivo prior to and following activation of the amyloid cascade, Neurodegenerative Dis, 7, 16, 10.1159/000283477 · DOI
- Jackson, 2017, Altered Synapse Stability in the Early Stages of Tauopathy, Cell Rep, 18, 3063, 10.1016/j.celrep.2017.03.013 · DOI
- Jha, 2018, Functional dissection of astrocyte-secreted proteins: Implications in brain health and diseases, Prog Neurobiol, 162, 37, 10.1016/j.pneurobio.2017.12.003 · DOI
- Jiang, 2018, TREM2 ameliorates neuronal tau pathology through suppression of microglial inflammatory response, Inflammation, 41, 811, 10.1007/s10753-018-0735-5 · DOI
- Josephs, 2011, Neuropathological background of phenotypical variability in frontotemporal dementia, Acta Neuropathol, 122, 137, 10.1007/s00401-011-0839-6 · DOI · Paper page
- Josephs, 2006, Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP, Neurology, 66, 41, 10.1212/01.wnl.0000191307.69661.c3 · DOI · Paper page
- Kaneko, 2010, Nasu-Hakola disease: the first case reported by Nasu and review, Neuropathology, 30, 70, 10.1111/j.1440-1789.2010.01127.x · DOI
- Karch, 2012, Extracellular Tau levels are influenced by variability in Tau that is associated with tauopathies, J Biol Chem, 287, 42751, 10.1074/jbc.M112.380642 · DOI · Paper page
- Kertesz, 2005, The evolution and pathology of frontotemporal dementia, Brain, 128, 1996, 10.1093/brain/awh598 · DOI · Paper page
- Kida, 1992, Immunohistochemical study of a case with progressive supranuclear palsy without ophthalmoplegia, Acta Neuropathol, 83, 328, 10.1007/BF00296797 · DOI
- Kim, 2019, Neuroinflammation in frontotemporal lobar degeneration revealed by 11C-PBR28 PET, Ann Clin Transl Neurol, 6, 1327, 10.1002/acn3.50802 · DOI
- Knopman, 2005, Antemortem diagnosis of frontotemporal lobar degeneration, Ann Neurol, 57, 480, 10.1002/ana.20425 · DOI · Paper page
- Kobayashi, 1999, KP1 expression of ghost Pick bodies, amyloid P-positive astrocytes and selective nigral degeneration in early onset Picks disease, Clin Neuropathol, 18, 240
- Kober, 2016, Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms, eLife, 5, e20391, 10.7554/eLife.20391 · DOI · Paper page
- Komori, 1998, Inducible nitric oxide synthase (iNOS)-like immunoreactivity in argyrophilic, tau-positive astrocytes in progressive supranuclear palsy, Acta Neuropathol, 95, 338, 10.1007/s004010050808 · DOI
- Kosik, 1989, Developmentally regulated expression of specific tau sequences, Neuron, 2, 1389, 10.1016/0896-6273(89)90077-9 · DOI · Paper page
- Krabbe, 2017, Microglial NFkappaB-TNFalpha hyperactivation induces obsessive-compulsive behavior in mouse models of progranulin-deficient frontotemporal dementia, 5029
- Lattante, 2013, TREM2 mutations are rare in a French cohort of patients with frontotemporal dementia, Neurobiol Aging, 34, 2443.e1, 10.1016/j.neurobiolaging.2013.04.030 · DOI
- Laurent, 2017, Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy, Brain, 140, 184, 10.1093/brain/aww270 · DOI · Paper page
- Laurent, 2014, Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology, Neurobiol Aging, 35, 2079, 10.1016/j.neurobiolaging.2014.03.027 · DOI · Paper page
- Lavisse, 2012, Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging, J Neurosci, 32, 10809, 10.1523/JNEUROSCI.1487-12.2012 · DOI · Paper page
- Lemstra, 2007, Microglia activation in sepsis: a case-control study, J Neuroinflammation, 4, 4, 10.1186/1742-2094-4-4 · DOI
- Ling, 2013, TDP-43 pathology in a patient carrying G2019S LRRK2 mutation and a novel p.Q124E MAPT, Neurobiol Aging, 34, 2889.e5, 10.1016/j.neurobiolaging.2013.04.011 · DOI
- Lively, 2018, Microglia responses to pro-inflammatory stimuli (LPS, IFNγ+TNFα) and reprogramming by resolving cytokines (IL-4, IL-10), Front Cell Neurosci, 12, 215, 10.3389/fncel.2018.00215 · DOI · Paper page
- Lladó, 2008, Clinicopathological and genetic correlates of frontotemporal lobar degeneration and corticobasal degeneration, J Neurol, 255, 488, 10.1007/s00415-008-0565-8 · DOI
- Lobo-Silva, 2016, Balancing the immune response in the brain: IL-10 and its regulation, J Neuroinflammation, 13, 297, 10.1186/s12974-016-0763-8 · DOI · Paper page
- Mederos, 2018, Astrocyte-neuron networks: a multilane highway of signaling for homeostatic brain function, Front Synaptic Neurosci, 10, 45, 10.3389/fnsyn.2018.00045 · DOI
- Merlini, 2018, Extravascular CD3+ T cells in brains of Alzheimer disease patients correlate with tau but not with amyloid pathology: an immunohistochemical study, Neurodegener Dis, 18, 49, 10.1159/000486200 · DOI · Paper page
- Mishra, 2017, Gene-based association studies report genetic links for clinical subtypes of frontotemporal dementia, Brain, 140, 1437, 10.1093/brain/awx066 · DOI
- Mishra, 2016, Astrocytes mediate neurovascular signaling to capillary pericytes but not to arterioles, Nat Neurosci, 19, 1619, 10.1038/nn.4428 · DOI · Paper page
- Mori, 2016, Neuroimmunology of the Interleukins 13 and 4, Brain Sci, 6, 18, 10.3390/brainsci6020018 · DOI
- Neher, 2019, Priming microglia for innate immune memory in the brain, Trends Immunol, 40, 358, 10.1016/j.it.2019.02.001 · DOI · Paper page
- Nguyen, 2018, G2019S LRRK2 enhances the neuronal transmission of tau in the mouse brain, Hum Mol Genet, 27, 120, 10.1093/hmg/ddx389 · DOI
- Nilsson, 2014, Age-related incidence and family history in frontotemporal dementia: data from the Swedish Dementia Registry, PLoS One, 9, e94901, 10.1371/journal.pone.0094901 · DOI
- Nimmerjahn, 2005, Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo, Science, 308, 1314, 10.1126/science.1110647 · DOI · Paper page
- Penkowa, 1999, Strongly compromised inflammatory response to brain injury in interleukin-6-deficient mice, Glia, 25, 343, 10.1002/(SICI)1098-1136(19990215)25:4<343::AID-GLIA4>3.0.CO;2-V · DOI · Paper page
- Persidsky, 1999, Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis, Am J Pathol, 155, 1599, 10.1016/S0002-9440(10)65476-4 · DOI · Paper page
- Pottier, 2016, TYROBP genetic variants in early-onset Alzheimer's disease, Neurobiol Aging, 48, 222.e9, 10.1016/j.neurobiolaging.2016.07.028 · DOI · Paper page
- Prebil, 2011, Dynamic monitoring of cytosolic glucose in single astrocytes, Glia, 59, 903, 10.1002/glia.21161 · DOI
- Rabinovici, 2010, Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management, CNS Drugs, 24, 375, 10.2165/11533100-000000000-00000 · DOI · Paper page
- Rakic, 2018, Systemic infection modifies the neuroinflammatory response in late stage Alzheimer's disease, Acta Neuropathol Commun, 6, 88, 10.1186/s40478-018-0592-3 · DOI
- Rascovsky, 2011, Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia, Brain, 134, 2456, 10.1093/brain/awr179 · DOI · Paper page
- Rascovsky, 2005, Rate of progression differs in frontotemporal dementia and Alzheimer disease, Neurology, 65, 397, 10.1212/01.wnl.0000171343.43314.6e · DOI · Paper page
- Reu, 2017, The lifespan and turnover of microglia in the human brain, Cell Rep, 20, 779, 10.1016/j.celrep.2017.07.004 · DOI · Paper page
- Romero-Molina, 2018, Distinct microglial responses in two transgenic murine models of TAU pathology, Front Cell Neurosci, 12, 421, 10.3389/fncel.2018.00421 · DOI
- Rubino, 2013, Apolipoprotein E polymorphisms in frontotemporal lobar degeneration: a meta-analysis, Alzheimers Dement, 9, 706, 10.1016/j.jalz.2012.10.013 · DOI
- Ruiz, 2014, Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia, Neurobiol Aging, 35, 444.e1-4, 10.1016/j.neurobiolaging.2013.08.011 · DOI · Paper page
- Salamanca, 2019, MIC-MAC: An automated pipeline for high-throughput characterization and classification of three-dimensional microglia morphologies in mouse and human postmortem brain samples, Glia, 67, 1496, 10.1002/glia.23623 · DOI
- Sanchez-Contreras, 2017, Study of LRRK2 variation in tauopathy: progressive supranuclear palsy and corticobasal degeneration, Mov Disord, 32, 115, 10.1002/mds.26815 · DOI
- Santacruz, 2005, Tau suppression in a neurodegenerative mouse model improves memory function, Science, 309, 476, 10.1126/science.1113694 · DOI · Paper page
- Santos, 2014, Reduced frequency of T lymphocytes expressing CTLA-4 in frontotemporal dementia compared to Alzheimer's disease, Progress Neuropsychopharmacol Biol Psychiatry, 48, 1, 10.1016/j.pnpbp.2013.06.019 · DOI
- Sasaki, 2008, Microglial activation in brain lesions with tau deposits: comparison of human tauopathies and tau transgenic mice TgTauP301L, Brain Res, 1214, 159, 10.1016/j.brainres.2008.02.084 · DOI
- Satoh, 2018, Alzheimer's disease pathology in Nasu-Hakola disease brains, Intractable Rare Dis Res, 7, 32, 10.5582/irdr.2017.01088 · DOI
- Schindowski, 2006, Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits, Am J Pathol, 169, 599, 10.2353/ajpath.2006.060002 · DOI · Paper page
- Schofield, 2003, Severity of gliosis in Pick’s disease and frontotemporal lobar degeneration: tau-positive glia differentiate these disorders, Brain, 126, 827, 10.1093/brain/awg085 · DOI
- Shi, 2005, Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation, Acta Neuropathol, 110, 501, 10.1007/s00401-005-1079-4 · DOI
- Shi, 2019, Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model, J Exp Med, 216, 2546, 10.1084/jem.20190980 · DOI · Paper page
- Shiarli, 2006, Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease, Neuropathol Appl Neurobiol, 32, 374, 10.1111/j.1365-2990.2006.00736.x · DOI
- Sidoryk-Wegrzynowicz, 2017, Astrocytes in mouse models of tauopathies acquire early deficits and lose neurosupportive functions, Acta Neuropathol Commun, 5, 89, 10.1186/s40478-017-0478-9 · DOI · Paper page
- Sloan, 2013, Glia as primary drivers of neuropathology in TDP-43 proteinopathies, Proc Natl Acad Sci USA, 110, 4439, 10.1073/pnas.1301608110 · DOI
- Snowden, 2011, The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships, Brain, 134, 2478, 10.1093/brain/awr189 · DOI · Paper page
- Sokolowski, 2011, Phagocytic clearance in neurodegeneration, Am J Pathol, 178, 1416, 10.1016/j.ajpath.2010.12.051 · DOI
- Spiller, 2018, Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy, Nat Neurosci, 21, 329, 10.1038/s41593-018-0083-7 · DOI · Paper page
- Stamatovic, 2008, Brain endothelial cell-cell junctions: how to "open" the blood brain barrier, Curr Neuropharmacol, 6, 179, 10.2174/157015908785777210 · DOI · Paper page
- Stancu, 2019, Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo, Acta Neuropathol, 137, 599, 10.1007/s00401-018-01957-y · DOI · Paper page
- Starhof, 2018, Cerebrospinal fluid pro-inflammatory cytokines differentiate parkinsonian syndromes, J Neuroinflammation, 15, 305, 10.1186/s12974-018-1339-6 · DOI
- Tacik, 2017, Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy, Neuropathol Appl Neurobiol, 43, 200, 10.1111/nan.12367 · DOI
- Taskesen, 2017, Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS, Sci Rep, 7, 8899, 10.1038/s41598-017-09320-z · DOI
- van Olst, 2020, Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model, Neurobiol Aging, 89, 89, 10.1016/j.neurobiolaging.2020.01.003 · DOI
- Venneti, 2013, Molecular imaging of microglia/macrophages in the brain, Glia, 61, 10, 10.1002/glia.22357 · DOI · Paper page
- Venneti, 2008, The positron emission tomography ligand DAA1106 binds with high affinity to activated microglia in human neurological disorders, J Neuropathol Exp Neurol, 67, 1001, 10.1097/NEN.0b013e318188b204 · DOI
- Wang, 2015, Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease, Ann Transl Med, 3, 136
- Woollacott, 2020, Microglial burden, activation and dystrophy patterns in frontotemporal lobar degeneration, J Neuroinflammation, 17, 234, 10.1186/s12974-020-01907-0 · DOI
- Wu, 2019, Complement C3 is activated in human AD brain and is required for neurodegeneration in mouse models of amyloidosis and tauopathy, Cell Rep, 28, 2111, 10.1016/j.celrep.2019.07.060 · DOI · Paper page
- Xiong, 2011, Clinical comparison of progressive aphasia associated with Alzheimer versus FTD-spectrum pathology, J Neurol Neurosurg Psychiatry, 82, 254, 10.1136/jnnp.2010.209916 · DOI
- Xu, 2014, Memory deficits correlate with tau and spine pathology in P301S MAPT transgenic mice, Neuropathol Appl Neurobiol, 40, 833, 10.1111/nan.12160 · DOI
- Yamada, 2014, Neuronal activity regulates extracellular tau in vivo, J Exp Med, 211, 387, 10.1084/jem.20131685 · DOI · Paper page
Cited by
Tauopathies: new perspectives and challenges
Zhang, Y., Wu, K.-M., Yang, L., Dong, Q., & Yu, J.-T. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00533-z · Cited by 323
Microglia and Astrocyte Function and Communication: What Do We Know in Humans?
Garland, E. F., Hartnell, I. J., & Boche, D. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.824888 · Cited by 165
“This emphasizes the need for human comparison, and in the last 20 years, the establishment of brain banks has facilitated the access of human tissue to researchers (Gomez-Nicola and Boche, 2015; Hartnell et al., 2021).”
BackgroundInfluentialSelf-citationPathogenic tau–induced transposable element–derived dsRNA drives neuroinflammation
Ochoa, E., Ramirez, P., Gonzalez, E., De Mange, J., Ray, W. J., Bieniek, K. F., & Frost, B. (2023) · Science Advances · doi:10.1126/sciadv.abq5423 · Cited by 73
Differences in peripheral immune system gene expression in frontotemporal degeneration
Sawyer, R. P., Hill, E. J., Yokoyama, J., Medvedovic, M., Ren, Y., Zhang, X., Choubey, D., Shatz, R. S., Miller, B., & Woo, D. (2022) · Medicine · doi:10.1097/md.0000000000028645 · Cited by 9
Metadata
- Authors
- Hartnell, I. J., Blum, D., Nicoll, J. A. R., Dorothee, G., & Boche, D.
- Affiliations
- Clinical Neurosciences, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK
- University of Lille, Inserm, CHU-Lille, UMR-S 1172—Lille Neuroscience and Cognition, Lille, France
- Inserm, Sorbonne University, UMRS 938 Saint-Antoine Research Center, Immune System and Neuroinflammation Laboratory, Hôpital Saint-Antoine, Paris, France
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-01-26
- Volume
- 144
- Issue
- 3
- Pages
- 724-745
- ISSN
- 0006-8950
- 1460-2156
- Cited by
- 42
- References
- 94
- Language
- en
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Funders
- Alzheimer’s Research UK (ARUK-PG2018A-012)
- ANR (ANR-18-CE16-0008)
- Network of Centres of Excellence in Neurodegeneration (CoEN 5008)
- Fondation Plan Alzheimer
- Fondation pour la Recherche Médicale
- LECMA/Fondation Vaincre Alzheimer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glial cells and adaptive immunity in frontotemporal dementia with tau pathology. https://app.cochat.ai/papers/10.1093/brain/awaa457
- The paper
- Hartnell, I. J., Blum, D., Nicoll, J. A. R., Dorothee, G., & Boche, D. (2021). Glial cells and adaptive immunity in frontotemporal dementia with tau pathology. Brain. https://doi.org/10.1093/brain/awaa457
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.